Skip to main content
Figure 4 | Lipids in Health and Disease

Figure 4

From: Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation of hypolipidemic effects of Calyx seu Fructus Physalis

Figure 4

Effects of the different fractions of CSFP on the TG content in HepG2 cells. a. TE: 50 μg/mL; B: 50 μg/mL; E: 50 μg/mL; W: 50 μg/mL. b. B1: 50 μg/mL; B2: 50 μg/mL; B3: 50 μg/mL; B4: 50 μg/mL. c. B2-1L: 10 μg/mL; B2-1H: 50 μg/mL; B2L: 10 μg/mL; B2H: 50 μg/mL. n = 3, * p < 0.05 compared with the model control group, Δ p ≤ 0.05 compared with the B2-1H group.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X